ArticleCureus2025
GANAB-Associated Severe Autosomal Dominant Polycystic Kidney Disease in an 18-Year-Old Female: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- GANAB-related Polycystic Kidney Disease Mimicking the Cutaneous Findings of Neurofibromatosis Type 1.Kidney medicine · 2026Article
- Toward Physiologically Relevant Organoid Models of Polycystic Kidney Disease through Microenvironment Reconstruction.Journal of the American Society of Nephrology : JASN · 2026Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autosomal dominant polycystic kidney disease (ADPKD) is a hereditary disorder, characterized by the formation of multiple cysts in the kidneys, leading to progressive kidney enlargement and, eventually, renal failure. It is most frequently associated with PKD1 or PKD2 mutations, although rare variants, such as the GANAB gene, are also associated, but they present as a milder renal phenotype. ADPKD patients often present with renal manifestations, such as hypertension, abdominal pain, hematuria, or urinary tract infections, along with extrarenal manifestations, such as liver cysts, heart valve disease, and cerebral aneurysms. ADPKD is usually diagnosed in the fourth or fifth decade of life. This case report discusses the clinical presentation, diagnostic approach, and management of an 18-year-old female patient with no known first-degree family history of ADPKD, who presented with hypertension and bilateral renal cysts on ultrasound. The diagnosis was confirmed by imaging studies and genetic testing. The GANAB gene mutation found in this patient is typically associated with mild kidney disease; however, according to the Mayo Clinic Imaging Classification (MIC) for ADPKD, our patient falls under Classification 1E, which is predictive of rapid progression to end-stage renal disease (ESRD). It highlights the challenges in treating young patients with ADPKD, given the limited studies available for managing this progressive disease in the young population. This case questions the assumption that GANAB-associated ADPKD progresses in a mild manner. Clinicians should prioritize vigilant monitoring and a multidisciplinary approach for young patients with high-risk imaging characteristics, regardless of their genetic findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.